{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:36:02Z","timestamp":1707525362656},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,6]]},"DOI":"10.7759\/cureus.46563","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T07:53:10Z","timestamp":1696578790000},"source":"Crossref","is-referenced-by-count":0,"title":["Septic Shock After Intravesical Therapy With Bacillus Calmette-Guerin: A Case Report of a Rare Life-Threatening Complication"],"prefix":"10.7759","author":[{"given":"Pedro Francisco","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaldo","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk M","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, et al.. European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ). Eur Urol. 2022, 81:75-94. 10.1016\/j.eururo.2021.08.010","journal-title":"Eur Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2020168","article-title":"Intravesical Bacillus Calmette-Guerin and its complications: 12 years of learning experience in a single local institution","volume":"63","author":"Yang X","year":"2022","unstructured":"Yang X, Toh Q, Huang HH, Sng LH, Tan TT, Ng LG. Intravesical Bacillus Calmette-Guerin and its complications: 12 years of learning experience in a single local institution. Singapore Med J. 2022, 63:325-9. 10.11622\/smedj.2020168","journal-title":"Singapore Med J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/362845","article-title":"Disseminated BCG: complications of intravesical bladder cancer treatment","volume":"2014","author":"To U","year":"2014","unstructured":"To U, Kim J, Chia D. Disseminated BCG: complications of intravesical bladder cancer treatment. Case Rep Med. 2014, 2014:362845. 10.1155\/2014\/362845","journal-title":"Case Rep Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.07.021","article-title":"Side effects of Bacillus Calmette-Gu\u00e9rin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG","volume":"65","author":"Brausi M","year":"2014","unstructured":"Brausi M, Oddens J, Sylvester R, et al.. Side effects of Bacillus Calmette-Gu\u00e9rin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG. Eur Urol. 2014, 65:69-76. 10.1016\/j.eururo.2013.07.021","journal-title":"Eur Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)37316-0","article-title":"Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer","volume":"147","author":"Lamm DL","year":"1992","unstructured":"Lamm DL, van der Meijden PM, Morales A, et al.. Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol. 1992, 147:596-600. 10.1016\/s0022-5347(17)37316-0","journal-title":"J Urol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000119","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature","volume":"93","author":"P\u00e9rez-Jacoiste As\u00edn MA","year":"2014","unstructured":"P\u00e9rez-Jacoiste As\u00edn MA, Fern\u00e1ndez-Ruiz M, L\u00f3pez-Medrano F, et al.. Bacillus Calmette-Gu\u00e9rin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature. Medicine (Baltimore). 2014, 93:236-54. 10.1097\/MD.0000000000000119","journal-title":"Medicine (Baltimore)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4137\/CCRep.S39904","article-title":"Disseminated Mycobacterium bovis infection complicating intravesical BCG instillation for the treatment of superficial transitional cell carcinoma of the bladder","volume":"9","author":"Elzein F","year":"2016","unstructured":"Elzein F, Albogami N, Saad M, El Tayeb N, Alghamdi A, Elyamany G. Disseminated Mycobacterium bovis infection complicating intravesical BCG instillation for the treatment of superficial transitional cell carcinoma of the bladder. Clin Med Insights Case Rep. 2016, 9:71-3. 10.4137\/CCRep.S39904","journal-title":"Clin Med Insights Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/821526","article-title":"Systemic BCG-Osis as a rare side effect of intravesical BCG treatment for superficial bladder cancer","volume":"2013","author":"Lukacs S","year":"2013","unstructured":"Lukacs S, Tschobotko B, Szabo NA, Symes A. Systemic BCG-Osis as a rare side effect of intravesical BCG treatment for superficial bladder cancer. Case Rep Urol. 2013, 2013:821526. 10.1155\/2013\/821526","journal-title":"Case Rep Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pulmoe.2019.10.001","article-title":"Disseminated Bacillus Calmette-Gu\u00e9rin (BCG) infection with pulmonary and renal involvement: a rare complication of BCG immunotherapy. A case report and narrative review","volume":"26","author":"Marques M","year":"2020","unstructured":"Marques M, Vazquez D, Sousa S, Mesquita G, Duarte M, Ferreira R. Disseminated Bacillus Calmette-Gu\u00e9rin (BCG) infection with pulmonary and renal involvement: a rare complication of BCG immunotherapy. A case report and narrative review. Pulmonology. 2020, 26:346-52. 10.1016\/j.pulmoe.2019.10.001","journal-title":"Pulmonology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2018.05.006","article-title":"A novel view on the pathogenesis of complications after intravesical BCG for bladder cancer","volume":"72","author":"Bilsen MP","year":"2018","unstructured":"Bilsen MP, van Meijgaarden KE, de Jong HK, et al.. A novel view on the pathogenesis of complications after intravesical BCG for bladder cancer. Int J Infect Dis. 2018, 72:63-8. 10.1016\/j.ijid.2018.05.006","journal-title":"Int J Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2020.1742475","article-title":"Disseminated BCG sepsis following intravesical therapy for bladder carcinoma: a case report and review of literature","volume":"10","author":"Oladiran O","year":"2020","unstructured":"Oladiran O, Nwosu I, Oladunjoye A, Oladunjoye O. Disseminated BCG sepsis following intravesical therapy for bladder carcinoma: a case report and review of literature. J Community Hosp Intern Med Perspect. 2020, 10:168-70. 10.1080\/20009666.2020.1742475","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-200624","article-title":"Concurrent granulomatous hepatitis, pneumonitis and sepsis as a complication of intravesical BCG immunotherapy","volume":"2013","author":"Delimpoura V","year":"2013","unstructured":"Delimpoura V, Samitas K, Vamvakaris I, Zervas E, Gaga M. Concurrent granulomatous hepatitis, pneumonitis and sepsis as a complication of intravesical BCG immunotherapy. BMJ Case Rep. 2013, 2013:10.1136\/bcr-2013-200624","journal-title":"BMJ Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.eucr.2017.04.009","article-title":"Case presentation: lung consolidation as sequelae of BCG sepsis after combined intravesical and intraurethral BCG","volume":"13","author":"Strich J","year":"2017","unstructured":"Strich J, Brancato S, Dolan R, et al.. Case presentation: lung consolidation as sequelae of BCG sepsis after combined intravesical and intraurethral BCG. Urol Case Rep. 2017, 13:152-3. 10.1016\/j.eucr.2017.04.009","journal-title":"Urol Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4236\/aid.2022.123041","article-title":"Genitourinary Bacillus Calmette-Guerin infection after BCG intravesical administration in a patient under hemodialysis\u2014what can we do better?","volume":"12","author":"Dias L","year":"2022","unstructured":"Dias L, Almeida C, Nogueira F, et al.. Genitourinary Bacillus Calmette-Guerin infection after BCG intravesical administration in a patient under hemodialysis\u2014what can we do better?. Advance Infect Dis. 2022, 12:563-7. 10.4236\/aid.2022.123041","journal-title":"Advance Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.7.3530-3532.2005","article-title":"Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis?","volume":"43","author":"de Jong BC","year":"2005","unstructured":"de Jong BC, Onipede A, Pym AS, Gagneux S, Aga RS, DeRiemer K, Small PM. Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis?. J Clin Microbiol. 2005, 43:3530-2. 10.1128\/JCM.43.7.3530-3532.2005","journal-title":"J Clin Microbiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/180235-septic-shock-after-intravesical-therapy-with-bacillus-calmette-guerin-a-case-report-of-a-rare-life-threatening-complication","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:39Z","timestamp":1707509319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/180235-septic-shock-after-intravesical-therapy-with-bacillus-calmette-guerin-a-case-report-of-a-rare-life-threatening-complication"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,6]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.46563","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,6]]}}}